While recent work suggests personality traits may be associated with hallmarks of Alzheimer’s pathology, it does not show cause-and-effect or associate these hallmarks with…
In our LiveTalk series, Being Patient spoke with Jason Ulrich, associate professor of neurology at Washington University in St. Louis, about the complex relationship between…
In our LiveTalk series, Being Patient explored the inner workings of the Wisconsin Registry for Alzheimer’s Prevention, a long-running study of people at risk…
What if we think of Alzheimer’s not as one disease, but three separate ones, with overlapping symptoms? Researchers behind a new study say Alzheimer’s…
The CEO of drug company AC Immune shared her thoughts on a recent failed tau vaccine trial, lessons learned, and what comes next. The…
Shedding further light on the mystery of Alzheimer’s pathology, a new study shows that individuals with a neurodegenerative language disorder called primary progressive aphasia…
While Biogen’s experimental Alzheimer’s treatment aducanumab faced yet another snag recently in its convoluted path toward FDA approval, other drugs companies are catching up:…